🇺🇸 FDA
Patent

US 7119103

β3-Adrenoreceptor agonists, agonist compositions and methods of using

granted A61PA61P3/04A61P3/08

Quick answer

US patent 7119103 (β3-Adrenoreceptor agonists, agonist compositions and methods of using) held by Molecular Design International, Inc. expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Molecular Design International, Inc.
Grant date
Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P3/04, A61P3/08, A61P3/10, A61P43/00